About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Journal of Men's Health

Editor-in-Chief: Ajay Nehra, MD

ISSN: 1875-6867 • Published Quarterly • Online ISSN: 1875-6859

Current Volume: 11

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    Manuscripts submitted to JOURNAL OF MEN’S HEALTH should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publication(s) should be described in the form of a footnote to the title. Articles should contain original data concerning the course (prognosis), cause (etiology), diagnosis, treatment, prevention, or economic analysis of a clinical disorder or an intervention to improve the quality of healthcare.  Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc. By submitting a manuscript to the Journal, the author(s) agree(s) to each of these conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal.


    Please read all the instructions to authors before submitting.


    All submissions must be in English. Appropriate use of the English language is a requirement for review and publication in Journal of Men’s Health.  For authors whose native language is not English, we suggest using a service that can aid in the translation and rewriting of material into correct and proper English usage.  The Publisher offers this service with a subsidy from the author prior to official submission.  It is important to note that employing the use of the Publisher’s service does not guarantee acceptance of any article.  Please contact AuthorServices@liebertpub.com for more information.

    Online Peer Review System

    Manuscripts must be submitted online using the following URL:


    Please read ALL instructions to authors before submitting. 

    If you do not have an account in Manuscript Central for Journal of Men’s Health, you will need to create one in order to submit.  Once you create your account, you may log in to the system to begin your submission.

    You will be asked to populate Manuscript Central with all data relevant to your manuscript.   Uploading your files will NOT enter the information contained within your article into the system.  All information must be provided in:  1) your manuscript, and 2) within Manuscript Central.



    All submissions to Journal of Men’s Health are subject to peer review. You will be asked for the names and email addresses of potential suggested reviewers familiar with the field. Please ensure preferred reviewers are not from your university or institution with whom you have collaborated. Anyone whom the author does not want to be considered may also be named as a non-preferred reviewer.  Ultimately, the final selection of reviewers is at the discretion of the Editor(s).



    All authors should be responsible for a significant part of the manuscript. All authors should have taken part in writing, reviewing, and revising the intellectual and technical content of the manuscript. Any author whose name appears on an article assumes responsibility and accountability for the results.


    Accuracy of Authorship  (Also see Copyright section)

    It is incumbent upon the submitting author/agent to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the article. Once an article is accepted for publication, changes in authorship while the article is in production – including page proofs – are NOT permitted. Changes in authorship after publication are strictly prohibited.



    It is the Journal’s policy that a manuscript declares only ONE corresponding author on an article.  This designation should be determined at the time of submission.  Additions to corresponding authors are not permitted after acceptance or in page proofs.

    Manuscript Preparation

    All manuscripts must be prepared in accordance with the “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.”




    Article Type


    Word Limit*

    Abstract Word Limit






    300 (structured)






















    Letter to the Editor






          *These limits relate to the text of the manuscript; word limits do NOT include the abstract, figure and/or table legends, acknowledgments, disclosures, or references.

    Requirements for text

    Prepare all text, double spaced, in Microsoft Word.  Do NOT supply a PDF of your manuscript. Provide the order of items as follows:

    • Title page
    • Abstract
    • Text
    • Acknowledgments
    • Author Disclosure Statement(s)
    • References
    • Correspondence address
    • Legends
    • Tables


    Requirements for Title Page

    The title page of your submission should be prepared in Microsoft Word and MUST be included as part of your main text document (not as a separate file) and should contain the following items:

    • The complete title of the article
    • All contributing authors’ full names, complete affiliation(s), including department, institution, city, state, country, full postal mailing address(es), and full contact information (telephone, fax, and email address)
    • A brief running title of no more than 50 characters, including spaces
    • The corresponding author’s complete contact information including address, working fax number, and email address
    • Between 3–6 keywords to assist in the peer-review process

    Requirements for Abstract

    • The abstract should be prepared in Microsoft Word
    • Abstract should be no more than 300 words
    • Abstract should be structured, stating the background, methods, results (including the sample size), and conclusions drawn from the study
    • The use of the first person should be avoided
    • Do not use proprietary or trade names in the title or abstract
    • Clearly summarize the results and conclusions of the work
    • References are not permitted in the abstract


    In general, the text should be organized under the headings: Introduction, Materials and Methods, Results, Discussion, Conclusion(s), Acknowledgment(s) Author Disclosure Statements, and References. Use only standard abbreviations, which can be found in the AMA’s Manual for Authors & Editors or the Council of Biology Editors Style Manual. At first usage, spell out terms and give abbreviations in parentheses. Thereafter, use only abbreviations. It is not necessary to spell out standard units of measure, even at first usage. Use generic names for drugs if possible. If you wish to use a proprietary drug name the first time it appears, use the generic name followed by the proprietary name, manufacturer, and manufacturer’s location in parentheses.


    Acknowledgments. The author should acknowledge only those people and their institutions that have made significant contributions to the study.


    Disclosure Statement. Immediately following the Acknowledgments section, include a section entitled, Author Disclosure Statement. In this portion of the article, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the article is being reviewed and will not influence the editorial decision. Please see the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals at www.icmje.org/recommendations/browse/roles-and-responsibilities/author-responsibilities--conflicts-of-interest.html for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist.”

    References. References must be prepared double spaced and numbered consecutively as they are cited in the text using superscript numbers. Do not include reference numbers in parentheses or brackets. References appearing for the first time in tables and figures must be numbered in sequence with those cited in the text where the table or figure is mentioned. Use journal abbreviations as provided by Medline. List all authors when there are six or fewer. When there are more than six authors, list the first three, followed by et al. If references to personal communications or unpublished data are used, they are not to be in the list of references. They should be referred to in the text in parentheses: (Example: F.P. Haseltine, personal communication). Include among the references any articles that have been officially accepted but not yet published; indicate the article title and the journal to which the work was accepted, and add “In Press.” 

    Sample references:

    • Journal article with up to six authors: Preyde M, Hatton-Bauer J, Cunningham C, Panjwani D. Evaluation of an informational pamphlet on distress and perceptions of supportive care for men with prostate cancer. J Men’s Health 2012;9:160–167.
    • Journal article with more than six authors: Sandhu NP, Brid Mac Bride M, Dilaveri CA, et al.  Male breast cancer. J Mens Health 2012;9:146–153.
    • Book:   Klabunde RE.  Cardiovascular Physiology Concepts.  Phildadelphia, PA: Lippincott Williams & Wilkins, 2011.
    • Chapter in a book:  Certo CM, De Turk WE, Cahalin LP.  History of Cardiopulmonary Rehabilitation  In:   De Turk WE, Cahalin LP,  editors. Cardiovascular and pulmonary physical therapy, second edition: an evidence-based approach.  New York, NY:  McGraw Hill-Medical, 2010. p.  3-15.
    • Websites: Please follow this structure for website references, including capitalization and punctuation:   List author/organization name (if available).  Article title.  List website address.  Last accessed on (include last date the site was accessed.)
    • Conference Proceedings: Please follow this structure for Conference Proceeding references, including capitalization and punctuation:  List all Authors’ (or) Editors’ names (last name first, followed by first and middle initials).  Conference title. Date of conference. Location of conference. City of publisher: Publisher; Year of publication. Complete number of pages in proceedings book.


    Correspondence Address. Following the references, provide the name, postal mailing address, and valid email address of the corresponding author.  If accepted, this information will be published and made available to the public.

    Legends. Supply a single, separate file containing all figure legends.  Provide a double-spaced legend for each supplied figure. Legends should be numbered consecutively. If applicable, provide explanations in the legend for any abbreviations, arrows, etc. in the figure. If a figure is being reprinted from a copyrighted publication, appropriate credit must be given in the legend.


    Tables. Prepare all tables double spaced in one separate Microsoft Word file (do NOT upload PDFs, .tifs, .eps files for tables).  Be sure to provide a title for each table. Cite tables in sequence in the text. Explain abbreviations used in the body of the table in footnotes. If a table is being reprinted from a copyrighted publication, appropriate credit must be supplied in a footnote.


    Figures.  Cite figures consecutively in the manuscript within parentheses: [Example: These keratotic areas can be confused with condyloma (Fig. 2A).]



    • Figures should be numbered in the order cited in the text.
    • Figures should not show the name of a patient or a manufacturer.
    • Name figure files using only alphanumeric characters.  Do not use symbols, dots, or dashes.
    • File names should be formatted with first author’s last name and the figure number. (Ex:  SmithFig1)
    • Do not embed any figures or tables in the main text file.
    • Do not prepare any figures in Word as they are not workable.
    • Save figures as either TIFF or EPS files. Avoid submitting JPEG files if possible.
    • PowerPoint files cannot be uploaded.
    • Line and graph figures should be submitted at a minimum of 600 DPI.
    • Halftones and color photos should be submitted at a minimum of 300 DPI.
    • Color figures must be saved as CYMK not RGB.
    • Publication of color figures is encouraged, but the cost for color printing must be subsidized by the author(s). Contact the Publisher for an estimate. Please consider these costs when preparing your manuscript for submission.




    Please upload individual files of all manuscript material — do NOT upload a single PDF file containing all text, figure, and table files of your article. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.


    Patient Release Information

    If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images of patients.  The submitting author should provide written confirmation of this critical information.  Acceptable forms of consent statements are emails or letters.  The Journal does not provide a generic patient release form.

    The written consent must contain specific information about the patient's name, age, and if pertinent, conservatorship – as well as stated permission – granting the Journal the rights to publish the photograph within its pages (which should include the name of the Journal and your article title).


    Patients and Study Participants

    All manuscripts must comply with the privacy and confidentiality requirements outlined on the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals website. For more information, visit www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html

    When articles include reports of studies on human subjects, state in the Methods section that an appropriate institutional review board or ethics committee approved the study. Authors who do not have formal ethics review committees should follow the principles of the Declaration of Helsinki. In the Methods section, state that informed consent was obtained from subjects (specify written or verbal).

    The principal author must state that if animals were used experimentally, permission was obtained from the appropriate committee(s), and that the animals were treated humanely and the standards conformed to those of current ethical animal research practices.

    In addition, text and photographs should not reveal any identifying information unless it is essential for scientific purposes (in which case, consent should be obtained). Masking the subjects’ eyes in photographs is often insufficient to protect their identity.






    When reporting experiments on people, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national), or if no formal ethics committee is available, with the Helsinki Declaration as revised in 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed.

    *This portion of the Instructions for Authors has been quoted directly from the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals website. For more information, visit www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html



    Materials taken from other sources must be accompanied by a written statement from the copyright holder (usually the publisher) giving permission to the Journal for reproduction. If clearance is required by the author’s institution, statements concerning such clearance should be provided in the manuscript. Obtain and submit written permission from authors to cite unpublished data or articles still in press.  Mary Ann Liebert, Inc. does not supply Permission Request Forms.



    Upon acceptance of any manuscript, EACH author listed on an article will receive a follow-up email with instructions to complete the online Copyright Agreement form.  It is critical to ensure the accuracy of ALL authors’ email addresses when uploading submissions to Manuscript Central to ensure the proper delivery of all email communications, particularly the Copyright Agreement.

    If you or your co-authors do not receive an email with a unique link to the copyright form, you may log on to the Manuscript Central system using the credentials with which you created your account.  Enter your Author Center and complete the forms located under “Manuscripts I Have Coauthored,” or “Manuscripts with Decisions” if you are listed as the corresponding author on the article.



    MANUSCRIPTS ARE NOT RELEASED INTO PRODUCTION UNTIL ALL AUTHORS HAVE COMPLETED THEIR INDIVIDUAL COPYRIGHT FORMS.  Failure by any author listed on an article to return their copyright form will result in a delay in publication.


    Page proofs will be sent to the (one) corresponding author as designated when the manuscript was uploaded to Manuscript Central.  It is the corresponding author’s responsibility to share the page proofs with co-authors and to coordinate all authors’ corrections into one proof.  The Publisher will not accept corrections from multiple authors. Changes in authorship in page proofs are NOT permitted under any circumstance.


    Reprints may be ordered by following the special instructions that will accompany page proofs and should be ordered at the time the corresponding author returns the corrected page proofs to the publisher. Reprints ordered after an issue is printed will be charged a substantially higher rate.


    NIH Public Access Policy

    In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final published article (after copyediting, author corrections, etc.) to PubMed Central (PMC) on behalf of the authors.  Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge.  Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

    Authors who would like their articles to be posted on LiebertPub.com immediately without this embargo period will have the option to make their articles available free online via Liebert Open Option for a one-time fee of $3,200. This fee also makes the article free in perpetuity on the LiebertPub.com site.

    Authors Funded by HHMI and Wellcome Trust: Please follow the instructions for Liebert Open Option above.


    The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; Fax: (914) 740–2108; Email: info@liebertpub.com

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy

    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 




The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    LGBT Health

    LGBT Health

    The peer-reviewed journal dedicated to promoting optimal healthcare for millions of sexual and gender minority persons worldwide.

    Journal of Women's Health

    Journal of Women's Health

    The primary source of information for meeting the challenges of providing optimal healthcare for women throughout their lifespan.

    Journal of Endourology
    and Part B, Videourology

    Journal of Endourology
    and Part B, Videourology

    The preeminent journal and videojournal for cutting-edge, minimally invasive and noninvasive surgical techniques and technologies in urologic surgery. Videourology™ is included with every subscription.

    Journal of Adolescent and Young Adult Oncology

    Journal of Adolescent and Young Adult Oncology

    The first cancer journal dedicated to the adolescent and young adult-aged oncology (AYAO) patient population. JAYAO is the only central forum for multidisiplinary, peer-reviewed articles, reviews, and research in the field.

Browse All Publications »